Skip to main content
OpenTrials
Completed

NCT Number: NCT04167904

Biomarkers in Patients Hospitalized With Suspected Acute Myocardial Infarction

The concentration of troponins in plasma is used for diagnosing acute myocardial infarction. Different types of heart-specific troponins can be measured and with different analytical methods. The primary aim of this study is to evaluate the diagnostic characteristics of a new analytical method for measuring troponin I in diagnosing acute myocardial infarction.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myocardial Infarction, Acute Cardiovascular Diseases Heart Diseases Hypersensitivity Immune System Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

St Olavs hospital

Trondheim, 7006, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • hospitalized at St. Olavs hospital
  • blood sampled for troponin analysis due to suspicion of acute myocardial infarction without ST-elevations on ECG less than 4 hours after admitted to the hospital

Exclusion criteria

  • residency outside Norway
  • does not understand Norwegian

Treatment and study plan

Primary outcomes

  1. Acute myocardial infarction according to the 4th universal definition of myocardial infarction

    Time frame: Before discharge from hospital, a median of 2 days

    Metric: Yes/No

Secondary outcomes

  1. Days between hospital discharge and death

    Time frame: Within 30 days after hospital discharge

    Metric: Days. The secondary outcome measures will be combined into a composite endpoint reflecting the time between hospital admission and the first secondary outcome measure

  2. Days between hospital discharge and acute myocardial infarction according to the 4th universal definition of myocardial infarction

    Time frame: Within 30 days after hospital discharge

    Metric: Days.

  3. Days between hospital discharge and coronary revascularization

    Time frame: Within 30 days after hospital discharge

    Metric: Days

Sponsors and collaborators

Lead sponsor

St. Olavs Hospital

Other

Collaborators

  • Norwegian University of Science and Technology

Registry information

Acronym: BIOMAC

Important dates

Study start
2019
Primary completion
2023
Study completion
2023
First posted
Nov 19, 2019
Registry last updated
Jun 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.